Data Presented at Major Medical Meeting Also Highlights Low Risk of Transplant-Related Complications with Genetically-Related Cord Blood Stem Cells SAN DIEGO -- In a retrospective review of blood disorder patients treated with stem cells from their own cord blood (autologous transplant) or from the cord blood of a sibling (allogeneic-related transplant), the majority of the patients were cured or achieved remission from their disease, according to a report presented today at the American Society for Blood and Marrow Transplantation (ASBMT) annual meeting.
He is a former member of the Board of Directors of the American Society for Blood and Marrow Transplantation (ASBMT) and a founding member of the International Society for Cellular Therapy (ISCT).
Alvarez is a member of numerous professional societies including the Society of Prenatal Care, American Institute of Ultrasound and Medicine and the American Society for Blood and Marrow Transplantation.
The Tandem BMT Meetings are the joint meeting of the American Society for Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant Research.
Xcyte") (Nasdaq:XCYT) announced today that results from two clinical trials of Xcellerated T Cells were presented at the 2005 Tandem BMT Meetings, the combined annual meeting of the American Society for Blood and Marrow Transplantation and the Center for International Blood & Marrow Transplant Research, which was held in Keystone, Colorado.
About the 2005 Tandem BMT Meetings The 2005 Tandem BMT Meetings are the joint meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood and Marrow Transplantation (CIBMTR, formerly IBMTR/ABMTR), and is the largest annual meeting of blood and marrow transplant specialists from around the world.
The abstract detailing the results of that study received the 2004 "Best Abstracts Award" by the American Society for Blood and Marrow Transplantation.
